Guangzhou Jet Biofiltration Co (SHSE:688026) Other Current Liabilities: ¥22.7 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688026 Guangzhou Jet Biofiltration Co Ltd SHSE:688026
74 GF Score
Price ¥18.19
GF Value ¥18.49
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Guangzhou Jet Biofiltration Co Other Current Liabilities?

Guangzhou Jet Biofiltration Co SHSE:688026 -1.94% 74 Other Current Liabilities is ¥22.7 Mil as of Mar. 2026. GuruFocus rates SHSE:688026 with a GF Score™ of 74/100 and a GF Value™ of ¥18.49 (Fairly Valued). The stock has 5 warning signs investors should review.

Guangzhou Jet Biofiltration Co's other current liabilities for the quarter that ended in Mar. 2026 was ¥22.7 Mil.

Guangzhou Jet Biofiltration Co's quarterly other current liabilities increased from Sep. 2025 (¥21.7 Mil) to Dec. 2025 (¥23.3 Mil) but then declined from Dec. 2025 (¥23.3 Mil) to Mar. 2026 (¥22.7 Mil).

Guangzhou Jet Biofiltration Co's annual other current liabilities declined from Dec. 2023 (¥33.8 Mil) to Dec. 2024 (¥19.8 Mil) but then increased from Dec. 2024 (¥19.8 Mil) to Dec. 2025 (¥23.3 Mil).

Guangzhou Jet Biofiltration Co Other Current Liabilities Related Terms

Guangzhou Jet Biofiltration Co Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Guangzhou Jet Biofiltration Co's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Guangzhou Jet Biofiltration Co Other Current Liabilities Chart

Guangzhou Jet Biofiltration Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 36.15 26.89 33.85 19.75 23.29

Guangzhou Jet Biofiltration Co Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 20.44 20.93 21.75 23.29 22.75
SHSE:688026
74GF Score
Guangzhou Jet Biofiltration Co Ltd SHSE:688026
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Guangzhou Jet Biofiltration Co Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of ¥22.7 Mil mean?
Guangzhou Jet Biofiltration Co (SHSE:688026) has a Other Current Liabilities of ¥22.7 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Guangzhou Jet Biofiltration Co.
Is Guangzhou Jet Biofiltration Co's Other Current Liabilities too high?
Guangzhou Jet Biofiltration Co's current Other Current Liabilities is ¥22.7 Mil. Overall, Guangzhou Jet Biofiltration Co has a GF Score™ of 74/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Guangzhou Jet Biofiltration Co's Other Current Liabilities compare to ISRG and BDX?
Guangzhou Jet Biofiltration Co's Other Current Liabilities of ¥22.7 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Guangzhou Jet Biofiltration Co. Guangzhou Jet Biofiltration Co's current Other Current Liabilities is ¥22.7 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Guangzhou Jet Biofiltration Co stock overvalued right now?
Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co (SHSE:688026) is currently considered Fairly Valued. The stock's GF Value™ is ¥18.49, compared to a current price of ¥18.19 — trading 1.6% below its estimated fair value. The current Other Current Liabilities is ¥22.7 Mil. Guangzhou Jet Biofiltration Co's overall GF Score™ is 74/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Guangzhou Jet Biofiltration Co (SHSE:688026), the current Other Current Liabilities is ¥22.7 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Guangzhou Jet Biofiltration Co (SHSE:688026) Overvalued in 2026?

Based on GuruFocus' analysis, Guangzhou Jet Biofiltration Co stock appears to be undervalued. The current stock price of ¥18.19 is trading 1.6% below its estimated GF Value™ of ¥18.49. GuruFocus considers Guangzhou Jet Biofiltration Co to be Fairly Valued.

Key valuation signals for SHSE:688026:

  • Other Current Liabilities: ¥22.7 Mil
  • GF Value™: ¥18.49 vs. price of ¥18.19 (1.6% below fair value)
  • GF Score™: 74/100 with 5 warning signs

No single metric tells the full story. See the SHSE:688026 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Guangzhou Jet Biofiltration Co Business Description

Address No. 1 Dou Tang Road, YongHe Development Zone, Guangzhou, CHN, 511356
Guangzhou Jet Biofiltration Co Ltd is engaged in the research and development, manufacturing and sales of laboratory consumable products. Its main products include laboratory consumables (pipettes, tissue culture products, centrifuge tubes, filtration products) analyzer, lab equipment and others.
74GF Score

Get the complete analysis for SHSE:688026

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥18.19
Price
¥18.49
GF Value